EUVIMEDEUVIMED entdecken
Crossref

The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer

Sijia Wu iD, Xinyu Qin, Liyu Huang

Human Molecular Genetics · 2024

DOI: 10.1093/hmg/ddae001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Sijia Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Xidian University, No. 2, South Taibai Road, Yanta district, Xi'an 710071, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Natural Science Foundation of Shaanxi Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The metastatic non-small cell lung cancer (NSCLC) is one of the cancers with high incidence, poor survival, and limited treatment. Epithelial-mesenchymal transition (EMT) is the first step by which an early tumor converts to an invasive one. Studying the underlying mechanisms of EMT can help the understanding of cancer metastasis and improve the treatment. In this study, 1013 NSCLC patients and 123 NSCLC cell lines are deeply analyzed for the potential roles of alternative polyadenylation (APA) in the EMT process. A trend of shorter 3′-UTRs (three prime untranslated region) is discovered in the mesenchymal samples. The identification of EMT-related APA events highlights the proximal poly(A) selection of CARM1. It is a pathological biomarker of mesenchymal tumor and cancer metastasis through losing miRNA binding to upregulate the EMT inducer of CARM1 and releasing miRNAs to downregulate the EMT inhibitor of RBM47. The crucial role of this APA event in EMT also guides its effect on drug responses. The patients with shorter 3′-UTR of CARM1 are more benefit from chemotherapy drugs, especially cisplatin. A stratification of NSCLC patients based on this APA event is useful for chemotherapy design in future clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansPolyadenylationCell Line, TumorEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticRNA-Binding Proteins

Stichwörter der Autor:innen

Alternative polyadenylationCisplatinEpithelial-mesenchymal transitionmiRNA regulationnon-small cell lung cancer

Substanzen

RBM47 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • School of Life Science and Technology, Xidian University, No. 2, South Taibai Road, Yanta district, Xi'an 710071, China.

ORCID-Profile: Sijia Wu

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Shaanxi Province of China
  • China Postdoctoral Science Foundation
  • National Key Research and Development Program of China

Zitieren

APA

Wu, S., Qin, X., & Huang, L. (2024). The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae001

Vancouver

Wu S, Qin X, Huang L. The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae001

BibTeX
@article{Wu2024,
  author = {Wu, Sijia and Qin, Xinyu and Huang, Liyu},
  title = {The role of alternative polyadenylation in epithelial-mesenchymal transition of non-small cell lung cancer},
  journal = {Human Molecular Genetics},
  year = {2024},
  doi = {10.1093/hmg/ddae001}
}
Kostenlos starten →